Stay updated on CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site-wide operating-status notice regarding government funding has been removed from the page.
    Difference
    0.5%
    Check dated 2025-11-18T06:50:01.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The screenshots show a redesigned header and revised layout on the Record History page, while the version list and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T20:40:32.000Z thumbnail image
  4. Check
    46 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    11%
    Check dated 2025-10-06T04:43:03.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new version but no substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-29T01:26:00.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing v3.0.1; the Back to Top link was removed. No other core content, pricing, stock, or time-slot information appears to have changed.
    Difference
    0.6%
    Check dated 2025-09-14T18:54:47.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.6%
    Check dated 2025-09-07T13:38:07.000Z thumbnail image

Stay in the know with updates to CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-99712 ADC in Relapsed/Refractory Multiple Myeloma Clinical Trial page.